Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-3
|
pubmed:dateCreated |
1995-7-14
|
pubmed:abstractText |
Zinc improves both insulin secretion and insulin sensitivity, and exerts insulin-like effects. We investigated its acute effects on the parameters of glucose assimilation determined with the minimal model technique from frequent sampling intravenous glucose tolerance test (FSIVGTT) in seven healthy volunteers. FSIVGTTs (0.5 g/kg of glucose, followed by 2 U insulin i.v. injection at 19 min) were performed after the subjects had taken 20 mg zinc gluconate twice (the evening before and 30 min before the beginning of the test) or placebo pills (simple blind randomized protocol). Glucose assimilation was analyzed by calculating Kg (slope of the exponential decrease in glycemia), glucose effectiveness Sg (i.e., ability of glucose itself to increase its own disposal independent of insulin response), and SI (insulin sensitivity, i.e. the effect of increases in insulinemia on glucose disposal). The two latter parameters were calculated by fitting the experimental data with the two equations of Bergman's "minimal model." Zinc increased Kg (p < 0.05) and Sg (p < 0.05), whereas SI and insulin first-phase secretion did not significantly increase. This study suggests that zinc improves glucose assimilation, as evidenced by the increase in Kg, and that this improvement results mainly from an increase in glucose effectiveness (insulin-like effect), rather than an action on insulin response or insulin sensitivity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Gluconates,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Placebos,
http://linkedlifedata.com/resource/pubmed/chemical/gluconic acid
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0163-4984
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
385-91
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7779574-Administration, Oral,
pubmed-meshheading:7779574-Adult,
pubmed-meshheading:7779574-Analysis of Variance,
pubmed-meshheading:7779574-Blood Glucose,
pubmed-meshheading:7779574-Female,
pubmed-meshheading:7779574-Gluconates,
pubmed-meshheading:7779574-Glucose Tolerance Test,
pubmed-meshheading:7779574-Humans,
pubmed-meshheading:7779574-Injections, Intravenous,
pubmed-meshheading:7779574-Insulin,
pubmed-meshheading:7779574-Least-Squares Analysis,
pubmed-meshheading:7779574-Male,
pubmed-meshheading:7779574-Placebos,
pubmed-meshheading:7779574-Single-Blind Method
|
pubmed:articleTitle |
Effects of oral zinc gluconate on glucose effectiveness and insulin sensitivity in humans.
|
pubmed:affiliation |
Hôpital Lapeyronie, Montpellier, France.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|